2019 Respiratory Inhalers Market Global Overview with AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Inc, etc
The Insight Partners’ report on the Respiratory Inhalers market aims at developing a better understanding of the Respiratory Inhalers industry through qualitative and quantitative analysis of the key market parameters. The Respiratory Inhalers market is classified on the basis of Types, Applications, and End-user, and the market is evaluated in terms of growth, value, and volume across five major geographical regions.
Inhalers for respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma are medical devices which deliver medicine to prevent, control and treat symptoms and help reduce exacerbations. There are many different types of inhaler, these variations can be confusing. The medicine inside an inhaler goes directly into the airways when the patient breathe in. Hence the patient requires much smaller dose of the medicine as compared to tablet or liquid.
Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00003093/
The Respiratory Inhalers Market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD), reduced patient discomfort for inhalers, and technological advancements in respiratory inhaler devices. Moreover, regulatory approvals for new and advanced respiratory inhaler pose growing opportunities for the growth of the global respiratory inhalers market.
Top Companies Profiles:
1.AstraZeneca
2. Beximco Pharmaceuticals Ltd.
3. Boehringer Ingelheim International GmbH
4. Cipla Inc
5. GlaxoSmithKline
6. Koninklijke Philips N.V.
7. OMRON Healthcare Europe B.V
8. PARI
9. Gecko Health
10. Inspiro Medical
The global respiratory inhalers market is segmented on the basis of product, technology, and disease indication. Based on product, the respiratory inhaler market is segmented as dry powder inhaler, metered dose inhaler, nebulizer. The nebulizer market is further segmented into mesh nebulizers, ultrasonic nebulizers, and compressed air nebulizers. By technology the market is segmented into manually operated inhaler devices and digitally operated inhaler devices. Based on disease indication, the respiratory inhaler market is segmented as asthma, COPD, pulmonary arterial hypertension and others respiratory disease.
North America is expected to contribute to the largest share in the respiratory inhalers market in the forecast period, due to the increasing prevalence COPD and asthma. Increase in number of patients affected by these diseases, increases the demand for respiratory inhalers, thereby boosting growth of this region. Also, availability of technologically advanced products in this region as well as the presence of major market players in this region contribute to the market growth. However, Asia Pacific region is expected to be the fastest growing region owing to availability of several untapped opportunities, growing awareness about the treatment of respiratory disorders amongst patients by supportive nongovernment organizations, such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and increasing adoption rate of respiratory devices in Asian countries, such as India and China.
Buy Now at https://www.theinsightpartners.com/buy/TIPRE00003093/
About us: –
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact us: –
Call: +1-646-491-9876
Email: [email protected]
